ArticleCancer immunology, immunotherapy : CII2012

Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ -independent resolution of treated-tumors and CD4+ -dependent systemic and memory responses.

Connie Jackaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.